Exhibit 23.2
LETTER OF CONSENT
We hereby consent to the reference to our report, as detailed below, in the annual report on form 20-F/A of XTL Biopharmaceuticals Ltd. (hereinafter: “XTL”) for the year ending December 31, 2016, dated March 30, 2017.
· | Impairment examination study of XTL’s intangible asset, dated March 31, 2016 |
/s/ BDO Ziv Haft Consulting and Management Ltd. |
Tel Aviv, Israel |
March 30, 2017 |